|
1
|
Boroughs LK and DeBerardinis RJ: Metabolic
pathways promoting cancer cell survival and growth. Nat Cell Biol.
17:351–359. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jansson MD and Lund AH: MicroRNA and
cancer. Mol Oncol. 6:590–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ling H, Fabbri M and Calin GA: MicroRNAs
and other non-coding RNAs as targets for anticancer drug
development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shen G, Li X, Jia YF, Plazza GA and Xi Y:
Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin.
34:336–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu G, Jiang P, Xiang Y and Zhang Y, Zhu Z,
Zhang C, Lee S, Lee W and Zhang Y: Increased expression of
protease-activated receptor 4 and Trefoil factor 2 in human
colorectal cancer. PLoS One. 10:e01226782015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun S, Jiang P, Su W, Xiang Y, Li J, Zeng
L and Yang S: Wild chrysanthemum extract prevents UVB
radiation-induced acute cell death and photoaging. Cytotechnology.
68:229–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moitra K, Im K, Limpert K, Borsa A,
Sawitzke J, Robey R, Yuhki N, Savan R, Huang da W, Lempicki RA, et
al: Differential gene and microRNA expression between etoposide
resistant and etoposide sensitive MCF7 breast cancer cell lines.
PLoS One. 7:e452682012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiang Y, Gao Q, Su W, Zeng L, Wang J, Hu
Y, Nie W, Ma X and Zhang Y, Lee W and Zhang Y: Establishment,
characterization and immortalization of a fibroblast cell line from
the Chinese red belly toad Bombina maxima skin. Cytotechnology.
64:95–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang YJ, Guo XL, Li SA, Zhao YQ, Liu ZC,
Lee WH, Xiang Y and Zhang Y: Prohibitin is involved in the
activated internalization and degradation of protease-activated
receptor 1. Biochim Biophys Acta. 1843:1393–1401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiang Y, Wang X, Yan C, Gao Q, Li SA, Liu
J, Zhou K, Guo X, Lee W and Zhang Y: Adenosine-5′-triphosphate
(ATP) protects mice against bacterial infection by activation of
the NLRP3 inflammasome. PLoS One. 8:e637592013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang Z, Bian X and Shim H: Inhibition of
breast cancer metastasis with microRNA-302a by downregulation of
CXCR4 expression. Breast Cancer Res Treat. 146:535–542. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Denoyelle C, Lambert B, Meryet-Figuière M,
Vigneron N, Brotin E, Lecerf C, Abeilard E, Giffard F, Louis MH,
Gauduchon P, et al: MiR-491-5p-induced apoptosis in ovarian
carcinoma depends on the direct inhibition of both BCL-XL and EGFR
leading to BIM activation. Cell Death Dis. 5:e14452014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng HL, Zhong Q, Qin YL, Bu QQ, Han XA,
Jia HT and Liu HW: Hypoxia-mimetic agents inhibit proliferation and
alter the morphology of human umbilical cord-derived mesenchymal
stem cells. BMC Cell Biol. 12:322011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai ZJ, Gao J, Ma XB, Yan K, Liu XX, Kang
HF, Ji ZZ, Guan HT and Wang XJ: Up-regulation of hypoxia inducible
factor-1a by cobalt chloride correlates with proliferation and
apoptosis in PC-2 cells. J Exp Clin Cancer Res. 31:282012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu X, Lu C, Liu H, Rao S, Cai J, Liu S,
Kriegel AJ, Greene AS, Liang M and Ding X: Hypoxic preconditioning
with cobalt of bone marrow mesenchymal stem cells improves cell
migration and enhances therapy for treatment of ischemic acute
kidney injury. PLoS One. 8:e627032013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Liu Y, Granberg KJ, Wang Q, Moore
LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, et al: Two
mature products of MIR-491 coordinate to suppress key cancer
hallmarks in glioblastoma. Oncogene. 34:1619–1628. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakano H, Miyazawa T, Kinoshita K, Yamada
Y and Yoshida T: Functional screening identifies a microRNA,
miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal
cancer cells. Int J Cancer. 127:1072–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lan A, Liao X, Mo L, Yang C, Yang Z, Wang
X, Hu F, Chen P, Feng J, Zheng D and Xiao L: Hydrogen sulfide
protects against chemical hypoxia-induced injury by inhibiting
ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells.
PLoS One. 6:e259212011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang WC, Chan SH, Jang TH, Chang JW, Ko
YC, Yen TC, Chiang SL, Chiang WF, Shieh TY, Liao CT, et al:
MiRNA-491-5p and GIT1 serve as modulators and biomarkers for oral
squamous cell carcinoma invasion and metastasis. Cancer Res.
74:751–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo M, Song LP, Jiang Y, Liu W, Yu Y and
Chen GQ: Hypoxia-mimetic agents desferrioxamine and cobalt chloride
induce leukemic cell apoptosis through different hypoxia-inducible
factor-1alpha independent mechanisms. Apoptosis. 11:67–77. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Harris AL: Hypoxia-a key regulatory factor
in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gilkes DM, Semenza GL and Wirtz D: Hypoxia
and the extracellular matrix: Drivers of tumour metastasis. Nat Rev
Cancer. 14:430–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. New Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chatterjee S, Behnam Azad B and Nimmagadda
S: The intricate role of CXCR4 in cancer. Adv Cancer Res.
124:31–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schwab LP, Peacock DL, Majumdar D, Ingels
JF, Jensen LC, Smith KD, Cushing RC and Seagroves TN:
Hypoxia-inducible factor 1a promotes primary tumor growth and
tumor-initiating cell activity in breast cancer. Breast Cancer Res.
14:R62012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marcus RE: The effect of low oxygen
concentration on growth, glycolysis, and sulfate incorporation by
articular chondrocytes in monolayer culture. Arthritis Rheum.
16:646–656. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sharma GD, He J and Bazan HE: P38 and
ERK1/2 coordinate cellular migration and proliferation in
epithelial wound healing: Evidence of cross-talk activation between
MAP kinase cascades. J Biol Chem. 278:21989–21997. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu Z and Xu S: ERK1/2 MAP kinases in cell
survival and apoptosis. IUBMB Life. 58:621–631. 2006. View Article : Google Scholar : PubMed/NCBI
|
